Liska Scheffers
Contact details
Liska is studying the pharmacokinetics and pharmacodynamics of therapeutic compounds to optimize chemotherapy timing and dosing for high-grade brain tumors, including diffuse midline glioma (DMG). These tumors are difficult to treat because the blood-brain barrier limits drug delivery to the brain. In addition to optimizing drug timing and dosing, focused ultrasound-mediated blood-brain barrier opening (FUS-BBBO) offers a promising strategy to improve drug delivery. By integrating preclinical, clinical, and modeling approaches, we aim to develop effective and clinically translatable treatment regimens for DMG.
- Publications